AffiliationNational University of Ireland Galway, Galway, Ireland; West Galway Mental Health Services, Health Service Executive West, Galway, Ireland.
MetadataShow full item record
CitationA case of paliperidone-palmitate-induced tardive dyskinesia. 2012: Gen Hosp Psychiatry
JournalGeneral hospital psychiatry
AbstractOBJECTIVES: This is one of the first cases reported in the literature of paliperidone-palmitate-induced prolonged dyskinesia. METHOD: Case report. RESULTS: We report the case of a 49-year-old woman with paranoid schizophrenia who developed orofacial dyskinesia some 4 months after the commencement of paliperidone long-acting injection. CONCLUSION: This case serves as a clinical reminder that dyskinesia can occur with all antipsychotic medications.
- Tardive dyskinesia induced by a switch from haloperidol depot to paliperidone palmitate.
- Authors: Hsu CY, Lin YH, Shen YC
- Issue date: 2013 Fall
- Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial.
- Authors: Bossie CA, Sliwa JK, Ma YW, Fu DJ, Alphs L
- Issue date: 2011 May 10
- Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication.
- Authors: Citrome L
- Issue date: 2010 Jan
- Paliperidone palmitate injection: Its efficacy, safety and tolerability in schizophrenia.
- Authors: Owen RT
- Issue date: 2010 Jul
- Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study: a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia.
- Authors: Alphs L, Mao L, Rodriguez SC, Hulihan J, Starr HL
- Issue date: 2014 Dec